Arvilommi, A.-M., et al., “Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1),” Eur. J Immunol. 26:825-833, VCH Verlagsgesellschaft mbH (1996). |
CAS Registry No. 13935-78-9, Chemical Abstracts Service (1992). |
CAS Registry No. 91182-14-8, Chemical Abstracts Service (No Entry/Publication date available). |
CAS Registry No. 91182-13-7, Chemical Abstracts Service (No Entry/Publication date available). |
CAS Registry No. 94467-44-4, Chemical Abstracts Service (No Entry/Publication date available). |
Huebner, C.F., et al., “Azodiformate adduct of indene and the stereochemistry of some 1,2-disubstituted indians,” Chem. Abstracts 72:121451t, American Chemical Society (1970). |
Lyles, G.A., “Mammalian Plasma and Tissue-bound Semicarbazide-sensitive Amine Oxidases: Biochemical, Pharmacological and Toxicological Aspects,” Int. J. Biochem. Cell Biol. 28:259-274, Pergamon Press (1996). |
Salmi, M. and Jalkanen, S., “A 90-Kilodalton Endothelial Cell Molecules Mediating Lymphocyte Binding in Humans,” Science 257:1407-1409, American Association for the Advancement of Science (1992). |
Salmi, M. and Jalkanen, S., “Human Vascular Adhesion Protein 1 (VAP-1) Is a Unique Sialoglycoprotein that Mediates Carbohydrate-dependent Binding of Lymphocytes to Endothelial Cells,” J. Exp. Med. 183:569-579, Rockefeller University Press (1996). |
Salmi, M., et al., “Induction and Function of Vascular Adhesion Protein-1 at Sites of Inflammation,” J. Exp. Med. 178:2255-2260, Rockefeller University Press (1993). |
Salmi, M., et al., “Homing of Mucosal Leukocytes to Joints. Distinct Endothelial Ligands in Synovium Mediate Leukocyte-subtype Secific Adhesion,” J. Clin. Invest. 99:2165-2172, American Society for Clinical Investigation (1997). |
Salmi, M., et al., “Vascular Adhesion Protein 1 (VAP-1) Mediates Lymphocyte Subtype-specific, Selectin-independent Recognition of Vascular Endothelium in Human Lymph Nodes,” J. Exp. Med. 186:589-600, Rockefeller University Press (1997). |
Salmi, M., et al., “A Cell Surface Amine Oxidase Directly Controls Lymphocyte Migration,” Immunity 14:265-276, Cell Press (Mar. 2001). |
Smith, D.J., et al., “Cloning of Vascular Adhesion Protein 1 Reveals a Novel Multifunctional Adhesion Molecule,” J. Exp. Med. 188:17-27, Rockefeller University Press (1998). |
Urry, W.H., et al., “Electrophilic Addition of 1,1-dimethyldiazenium bromide with 1,3-dienes and styrenes,” Chem. Abstracts 61:2992c, American Chemical Society (1964). |
Von Gustorf, K., et al., “Photochemical and thermal 1,2- and 1,4-cycloaddition reactions of azodicarbonyl compounds with monoolefins,” Chem. Abstracts 72:121454w, American Chemical Society (1970). |
Adams, M. A., et al. “Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple and overlapping systems.” International Journal of Impotence Research, vol. 9, 1997, pp. 85-91. |
Lee, Robert, et al. “Debate: vascular remodeling.” Journal of Hypertension, vol. 15, 1997, pp. 333-337. |
Lundie, Mark, et al. “Long-term inhibition of the renin-anglotensin system in genetic hypertension: analysis of the impact on blood pressure and cardiovascular structural changes.” Journal of Hypertension, vol. 15, 1997, pp. 339-348. |
Adams, Michael A., et al. “Common features regulating the systemic circulation and the penile vasculature.” Erectile Dysfunction. pp. 27-38. London: Martin Dunitz Ltd, 1998. |
Okabe, H., et al. “The penis is not protected—in hypertension there are vascular changes in the penis wich are similar to those in other vascular beds.” International Journal of Impotence Research, vol. 11, 1999, pp. 133-140. |
Adams, M.A., et al., “Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats.” Journal of Hypertension, vol. 16, No. 3, pp. 252-260 (1990). |
Adams, M. A., et al., “Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple and overlapping systems.” International Journal of Impotence Research, vol. 9, pp. 85-91 (1997). |
Adams, M.A., et al., “Evidence in vivo for induction of cardiovascular growth processes by vasoconstrictor systems.” Blood Pressure, vol. 4, (Suppl 2), pp. 61-67 (1995). |
Banting, J.D.,et al., “Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade.” Hypertension, vol. 30, No. 3, Part 1, pp. 416-421 (1997). |
Childs, T.J., et al., “Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins.” Hypertension, vol. 16, No. 6, pp. 662-668 (1990). |
Christensen, K.L., et al., “Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.” Hypertension, vol. 7, No. 2. pp. 83-90 (1989). |
Dukacz, S.A.W., et al., “The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats.” American Journal of Physiology, vol. 273, pp. F104-F112 (1997). |
Friberg, P., et al., “Cardiac and vascular structural adaption in experimental hypertension.” European Heart Journal, vol. 11, (Supplement G), pp. 65-71 (1990). |
Gohlke, P., et al., “Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses.” Journal of Hypertension, vol. 10, (supplement 6), pp. S141-S144 (1992). |
Harrap, S.B., et al., “Proceedings of the HBPRCA. Transplantation studies of the role of the kidney in long-term blood pressure reduction folowing brief ACE inhibitor treatment in yound spontaneously hypertensive rats.” Clinical and Experimental Pharmacology and Physiology, vol. 21, pp. 129-131 (1994). |
Jespersen, L.T., et al., “Cardiac mass and peripheral vascular structure in hydralazine-treated spontaneously hypertensive rats.” Hypertension, vol. 7, No. 5, pp. 734-741 (1985). |
Kett, M.M., et al., “Enalapril does not prevent renal arterial hypertrophy in spontaneously hypertensive rats.” Hypertension, vol. 25, No. 3, pp. 335-342 (1995). |
Lee, R.M.K.W., et al., “Debate: vascular remodelling.” Journal of Hypertension, vol. 15, pp. 333-337 (1997). |
Lundie, M.J., et al., “Long-term inhibition of the renin-angiotensin system in genetic hypertension: analysis of the impact on blood pressure and cardiovascular structural changes.” Journal of Hypertension, vol. 15, No. 4, pp. 339-348 (1997). |
Moreau, P., et al., “Angiotensin II increases tissue endothelin and induces vascular hypertrophy. Reversal by ETA-receptor antagonist.” Circulation, vol. 96, No. 5, pp. 1593-1597 ((1997). |
Morton, J.J., et al., “Angiotensin II receptor antagonist losartan has persistant effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure.” Journal of Vascular Research, vol. 29, pp. 264-269 (1992). |
Nyborg, N.C.B., et al., “Lack of effect of anti-hypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats.” Cardiovascular Research, vol. 19, pp. 528-536 (1985). |
Rizzoni, D., et al., “Effects of losartan and enalapril on small artery structure in hypertensive rats.” Hypertension, vol. 32, pp. 305-310 (1998). |
Sano, T., et al., “Differential structural responses of small resistance vessels to antihypertensive therapy.” Circulation, vol. 75, No. 3, pp. 618-626 (1987). |
Shartl, M., et al., “Remodeling of myocardium and arteries by chronic angiotensin converting enzyme inhibition in hypertensive patients.” Abstract, Journal of Hypertension, vol. 12, Suppl. 4, pp. S37-S42 (1994). |
Thybo, N.K., et al., “Dose-dependent effects of perindopril on blood pressure and small-artery structure.” Hypertension, vol. 23, No. 5, pp. 659-666 (1994). |
Wahlander, H., et al., “Therapeutic, but not low-dose, angiotensin-converting enzyme inhibition causes regression of cardiovascular changes in spontaneously hypertensive rats.” Journal of Cardiovascular Pharmacology, vol. 27, pp. 327-334 (1996). |
Weiss, L., “Long-term treatment with antihypertensive drugs in spontaneously hypertensive rats (SHR). Effects on blood pressure, survival rate and cardiovascular design.” Acta. Physiol. Scand., vol. 91, pp. 393-408 (1974). |